Stock APLS APELLIS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Apellis Pharmaceuticals, Inc.

Equities

APLS

US03753U1060

Market Closed - Nasdaq
Other stock markets
 03:59:52 2024-05-29 pm EDT 		5-day change 1st Jan Change
41.15 USD +1.45% Intraday chart for Apellis Pharmaceuticals, Inc. -5.62% -31.26%
May. 24 Apellis Pharmaceuticals, Sobi Say Pegcetacoplan Reduces Post-Transplant Kidney Diseases MT
May. 24 Apellis Pharmaceuticals, Inc. Announces Positive One-Year Data from Phase 2 Study of Pegcetacoplan in Post-Transplant Recurrence of C3G and IC-MPGN Presented as Late-Breaker at ERA Congress CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
APELLIS PHARMACEUTICALS, INC.
Biopharmaceuticals
+1.45%-5.62%-31.26%-52.68%+96.80% 4.99B
Bearish
Bearish
Neutral
  1. Stock Market
  2. Equities
  3. APLS Stock
  4. Charts Apellis Pharmaceuticals, Inc.
  5. Relative Strength Chart